Cornerstone Capital Management Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$21.3M	Buy	347,968 +12,626	+4%	+$790K	0.15%	153
2017 Q3	$21.4M	Buy	335,342 +3,016	+0.9%	+$176K	0.17%	146
2017 Q2	$18.5M	Sell	332,326 -9,323	-3%	-$507K	0.15%	156
2017 Q1	$18.6M	Sell	341,649 -26,388	-7%	-$1.45M	0.14%	165
2016 Q4	$21.5M	Sell	368,037 -36,301	-9%	-$1.98M	0.17%	131
2016 Q3	$21.8M	Sell	404,338 -12,770	-3%	-$820K	0.16%	128
2016 Q2	$30.7M	Sell	417,108 -68,791	-14%	-$4.86M	0.25%	64
2016 Q1	$31M	Sell	485,899 -27,388	-5%	-$1.73M	0.26%	62
2015 Q4	$35.3M	Buy	513,287 +12,142	+2%	+$802K	0.29%	52
2015 Q3	$29.7M	Buy	501,145 +48,666	+11%	+$3.09M	0.28%	56
2015 Q2	$30.1M	Sell	452,479 -13,230	-3%	-$872K	0.27%	62
2015 Q1	$30M	Buy	465,709 +31,336	+7%	+$1.96M	0.28%	61
2014 Q4	$25.6M	Buy	434,373 +27,897	+7%	+$1.57M	0.26%	82
2014 Q3	$20.8M	Sell	406,476 -344	-0.1%	-$17.2K	0.23%	105
2014 Q2	$19.7M	Sell	406,820 -11,492	-3%	-$566K	0.22%	116
2014 Q1	$21.7M	Sell	418,312 -27,380	-6%	-$1.46M	0.25%	86
2013 Q4	$23.7M	Sell	445,692 -368,598	-45%	-$18.8M	0.27%	80
2013 Q3	$37.7M	Buy	814,290 +23,450	+3%	+$1.03M	0.45%	39
2013 Q2	$35.3M	Buy	+790,840	New	+$34.3M	0.44%	40

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's BMY Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Bristol-Myers Squibb (BMY) stake by 3.8% in Q4 2017, buying an estimated $790K and bringing the position to 347,968 shares worth $21.3M. The position accounts for 0.15% of the portfolio, ranked #153.

Cornerstone Capital Management Holdings first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $37.7M in Q3 2013. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Cornerstone Capital Management Holdings held 347,968 shares of Bristol-Myers Squibb worth $21.3M as of Q4 2017.
Cornerstone Capital Management Holdings bought 12,626 Bristol-Myers Squibb shares in Q4 2017, an estimated $790K.
Bristol-Myers Squibb made up 0.15% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #153 holding.
Cornerstone Capital Management Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
Cornerstone Capital Management Holdings's Bristol-Myers Squibb position peaked at $37.7M in Q3 2013.
1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.